Related Experiment Videos
[Modern pathogenetic-therapeutic approaches in glaucoma].
C Constantin1, D Costin, D Chiseliţă
1Clinica II Oftalmologie, Iaşi.
Oftalmologia (Bucharest, Romania : 1990)
|October 6, 2000
Summary
This review explores apoptosis in glaucoma, focusing on neuroprotective drugs. New therapies will complement existing glaucoma treatments for better outcomes.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Context:
- Glaucoma pathogenesis research is evolving.
- Understanding apoptosis is crucial for glaucomatous neuropathy.
- Current research investigates molecular mechanisms underlying optic nerve damage.
Purpose:
- To review current understanding of apoptosis in glaucoma.
- To discuss substances and transmitters involved in apoptosis.
- To introduce novel neuroprotective medications for glaucoma.
Summary:
- The review covers new directions in glaucoma pathogenesis research.
- It examines the role of apoptosis in developing glaucomatous neuropathy.
- Substances and transmitters influencing apoptosis, along with new neuroprotective drugs, are discussed.
Impact:
- Novel neuroprotective therapies are emerging for glaucoma management.
- These new treatments are expected to be adjunctive to established glaucoma therapies.
- This research may lead to improved therapeutic strategies for preserving vision in glaucoma patients.